LivaNova PLC

S&P 500

LIVN/Healthcare · Medical Devices/NASDAQ

Stock Price

$81.05

Stock Price$81.05P/E40.1MCap4.3BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

LIVN does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About LivaNova PLC

LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression, along with advanced cardiopulmonary solutions for cardiac surgical procedures. LivaNova serves healthcare providers and patients worldwide, addressing critical medical needs in neurology and cardiovascular care. Established through the 2015 merger of Cyberonics and Sorin, the company combines decades of expertise in both neuromodulation and cardiopulmonary innovation. Operating through specialized business units headquartered in different regions, LivaNova also maintains a digital health initiative focused on epilepsy treatment support. The company is headquartered in London and employs thousands of professionals dedicated to transforming patient outcomes through advanced medical technology solutions.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$41.01 - $82.66

Earnings & Profitability

LIVN earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

LIVN Dividend Calculator

Number of Shares

Total Investment

$8,105.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is LIVN's current dividend yield?

LivaNova PLC (LIVN) currently has a dividend yield of 0.00%, based on a stock price of $81.05 and an annual dividend of $0.00.

When is LIVN's next dividend payment date?

LIVN's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does LIVN pay in dividends per year?

LivaNova PLC pays dividends unknown. Annual dividend data is not yet available.

Has LIVN been increasing its dividend?

LivaNova PLC has grown its dividend at a 5-year CAGR of —.

Is LIVN's dividend safe?

LivaNova PLC has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is LIVN's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates LivaNova PLC's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track LIVN Dividends with OnlyDividends

What will LIVN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.